Soligenix Announces European Patent Grant for Use of Dusquetide in Oral Mucositis
CIProud.com,
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Please enter a search term. Please enter a search term. News provided by May 16, 2023, 7:30 AM ET Peptides for specific use in…
Soligenix Announces European Patent Grant for Use of Dusquetide in Oral Mucositis PR Newswire PRINCETON, N.J., May 16, 2023…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims, - Soligenix, Inc.
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims, - Soligenix, Inc.
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J.
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims About Oral Mucositis Oral…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
Peptides for specific use in oral mucositis treatment adds to existing composition of matter claims PRINCETON, N.J., May 16…
PRINCETON, N.J. - (Nasdaq: SNGX) ( or the Company), a late-stage biopharmaceutical company focused on developing and…
SOURCE Soligenix, Inc.PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Key Binding Characteristics of Dusquetide to Important Intracellular Protein Identified PR Newswire PRINCETON, N.J., June 1…
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
? uncertainty inherent in developing therapeutics and vaccines, and manufacturing and conducting preclinical and clinical trials…
With two Phase 3 assets approaching clinical trial readouts, a government-funded vaccine program including a potential COVID-19…
Soligenix is a small biotech company with just ~$20M market cap. In the near future, the company will complete two Phase 3…
SOURCE Soligenix, Inc. Enrollment Sufficient to Support the Interim Efficacy Analysis PRINCETON, N.J.
SOURCE Soligenix, Inc. Enrollment Sufficient to Support the Interim Efficacy Analysis PRINCETON, N.J.
SOURCE Soligenix, Inc. Enrollment Sufficient to Support the Interim Efficacy Analysis PRINCETON, N.J.
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Enrollment Sufficient to Support the Interim Efficacy Analysis PRINCETON, N.J., April 18, 2019 /PRNewswire/ -- Soligenix, Inc.
Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing Authorization…
SOURCE Soligenix, Inc. Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing…
SOURCE Soligenix, Inc. Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing…
SOURCE Soligenix, Inc. Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing Authorization…